• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Mackenzie's Mission HomepageMackenzie's Mission

DONATE Mackenzies Mission Donate
  • Mission
  • About
    • The Story
    • Board
  • Resources
    • Resource List
    • What Is Amyloidosis
  • Speakers Bureau
    • About ASB
    • ASB Operating Committee
  • Fundraisers
  • Blog
  • Contact

AL amyloidosis

Peripheral Neuropathy & Amyloidosis

May 26, 2022

Neuropathy, also known as peripheral neuropathy, is a broad term that is used to describe damage to the nerves outside of the brain and spinal cord. There are over 100 types of peripheral neuropathy that can be classified into four categories, with each type having their own symptoms and prognosis. In this article, we’ll discuss the types of peripheral neuropathy and its connection to amyloidosis.

Filed Under: Featured News, What Is Amyloidosis Tagged With: AL amyloidosis, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, attrv, ATTRwt, diagnosing amyloidosis, hATTR, Hereditary Amyloidosis, light chain amyloidosis, wild-type amyloidosis

Cardiomyopathy & Amyloidosis

April 28, 2022

Cardiomyopathy is a broad term that is used to describe disease of the heart muscle, making it difficult for the heart to provide the body with an adequate blood supply. It can lead to heart failure and even death. In this article, we’ll discuss the types of cardiomyopathy and its connection to amyloidosis.

Filed Under: Featured News, What Is Amyloidosis Tagged With: AL amyloidosis, amyloid protein, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, ATTRwt, cardiac amyloidosis, cardiomyopathy, heart failure

Proteinuria & Amyloidosis

February 24, 2022

Proteinuria, which has been described as foamy urine, is a common symptom of multiple conditions and diseases. It can be temporary, or persistent, depending on the associated cause. Amyloidosis may be one of those causes.

Filed Under: Featured News, What Is Amyloidosis Tagged With: AL amyloidosis, amyloidosis, amyloidosis diagnosis, diagnosing amyloidosis, light chain amyloidosis, raising awareness

ASB: 2021 Year-End Review

December 14, 2021

The Amyloidosis Speakers Bureau (ASB) had a wonderful year in 2021, settling into a new normal of virtual presentations. We gave 61 presentations to 2,400 U.S. medical students and internal medicine residency programs. We invite you to read more about our exciting and trajectory-changing educational initiative.

Filed Under: Featured News, Mission News, Speakers Bureau News Tagged With: AL amyloidosis, amyloidosis, amyloidosis diagnosis, amyloidosis speakers bureau, ATTR amyloidosis, ATTRwt, diagnosing amyloidosis, light chain amyloidosis, patientsteachingstudents, raising awareness, wild-type amyloidosis

THE POWER OF THE PATIENT/PHYSICIAN COLLABORATION

December 7, 2021

This excellent video showcases how physicians can collaborate with their patients to work towards a diagnosis. When dealing with an uncommon disease, it’s critical for physicians to be curious, ask questions, and listen.

Filed Under: Featured News, Speakers Bureau News, What Is Amyloidosis Tagged With: AL amyloidosis, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, ATTRwt, cardiac amyloidosis, diagnosing amyloidosis, light chain amyloidosis, patientsteachingstudents, raising awareness, wild-type amyloidosis

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

Recent News

  • FACES of Amyloidosis 2023
  • Hereditary Amyloidosis: The T60A Variant
  • Worldwide Hotspots of Hereditary ATTR Amyloidosis (ATTRv)
  • 2022: Mackenzie’s Mission – Our Report Card
  • CRISPR/Cas9 – ATTR Clinical Trial Update

Be A Part Of Our Mission!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

  • Mission
  • About
  • Resources
  • Speakers Bureau
  • Fundraisers
  • Blog
  • Contact

Registered 501(c)(3) · Contact · Copyright © 2023 · Mackenzies Mission - All Rights Reserved